Korea Stocks — 39 / 40

Korea Stocks, page 39 of 40 — 24 articles published 2026-05-20 ~ 2026-06-24.

June 24, 2026

Lunit (328130) Stock Outlook 2026: Can the AI Medical Imaging Leader Reach Profitability?

Lunit (KRX 328130) 2026 stock outlook. A qualitative deep dive into Lunit INSIGHT for AI-assisted cancer detection in chest X-ray and mammography, Lunit SCOPE for pathology biomarkers and companion diagnostics, the Volpara acquisition opening the US breast health market, and global pharma partnerships. We weigh the path to profitability against valuation and FDA regulatory risk for this loss-making growth stock.

Lunit 328130 Korea Stocks

June 24, 2026

Samsung Electro-Mechanics (009150) Stock Outlook 2026: The MLCC Cycle and the AI Substrate Engine

Samsung Electro-Mechanics (KRX 009150) 2026 stock outlook. A deep qualitative analysis of its world No.2 MLCC position, high-value automotive and AI-server capacitors, FC-BGA semiconductor substrates riding AI demand, camera modules, the smartphone and MLCC price-cycle risk, and how US investors can approach this Korean components play.

009150 Samsung Electro-Mechanics MLCC

June 24, 2026

Soulbrain (357780) Stock Outlook 2026: A Semiconductor Materials Moat Tied to the Memory Cycle

Soulbrain (KRX 357780) 2026 stock outlook. A qualitative deep dive into its ultra-high-purity etchants (hydrofluoric acid / HF and phosphoric-acid etchants), CMP slurries, ALD/CVD precursors, plus display materials and battery electrolytes — and how materials localization, higher-layer NAND and finer DRAM drive demand against memory-cycle and customer-concentration risk.

Soulbrain 357780 semiconductor materials

June 24, 2026

Techwing (089030) Stock Outlook 2026: Cube Prober and the HBM Test Pivot

Techwing (KRX 089030) 2026 stock outlook. The world's No.1 memory test handler moat, the Cube Prober growth engine for wafer-level HBM testing, exposure to the SK Hynix and Micron HBM value chain, and the real risks around mass-production qualification, customer concentration, and the memory cycle, analyzed qualitatively for global investors trading Korean semiconductor equipment names.

Techwing 089030 Cube Prober

June 24, 2026

Wemade (112040) Stock Outlook 2026: The High-Volatility Dilemma of a Crypto-Linked Game Stock

Wemade (KRX 112040) 2026 stock outlook. A deep qualitative analysis of Mir4 and Night Crows global hits, the WEMIX blockchain gaming ecosystem, the Play-to-Earn business model, and the structural risks of crypto price volatility, P2E regulation, exchange delisting history, hit-game dependence, and cash flow for global blockchain gaming investors.

Wemade 112040 WEMIX

June 24, 2026

Wonik IPS (KRX 240810) Stock Outlook 2026: A Korean Front-End Equipment Play on the Memory Capex Cycle

Wonik IPS (KRX 240810) 2026 stock outlook. A deep, qualitative analysis of its deposition (CVD/ALD), etch and thermal front-end semiconductor equipment business, dependence on Samsung and SK Hynix capex, the localization tailwind, HBM and DRAM/NAND capacity investment, plus customer-concentration and memory-cycle risks — framed against US equipment giants AMAT and LRCX.

240810 Wonik IPS semiconductor equipment

June 23, 2026

Samsung SDS Stock Outlook 2026: Captive Cash Flow Meets the Generative-AI Re-Rating Bet

Samsung SDS (018260) 2026 stock analysis: the two-segment structure of IT Services (cloud SCP, system integration, FabriX/Brity generative AI) and Logistics (Cello digital forwarding), Samsung captive reliance, freight-rate volatility, strong balance sheet and dividend, AI optionality, and governance overhang.

Samsung SDS 018260 Korea Stocks

June 23, 2026

LG H&H Stock Outlook 2026: The De-Rated Compounder Between China Recovery and Beverage Cash Flow

LG Household & Health Care (051900) 2026 stock analysis: three divisions — Beauty (The History of Whoo luxury cosmetics), Home & Daily Beauty, and Coca-Cola Korea bottling. China demand recovery, duty-free/daigou normalization, Whoo brand reset, dividend, and why this de-rated compounder cushions cosmetics cyclicality with stable beverage cash flow.

051900 LG H&H Korean Stocks

June 23, 2026

Kakao Games Stock Outlook 2026: New-Title Momentum vs. Single-Hit Dependence (293490)

Kakao Games (293490, KOSDAQ) 2026 stock analysis: a Korean game publisher-developer under the Kakao umbrella. Odin's legacy, the new-title pipeline, global publishing, platform leverage, hit-driven earnings volatility, probability-item regulation, and parent-governance overhang — compared with Krafton, NCSoft, Netmarble, and Pearl Abyss.

Kakao Games 293490 Korean game stocks

June 23, 2026

Yuhan Corporation Stock Outlook 2026: A Value Pharma Re-Rated by a J&J Oncology Royalty

Yuhan Corporation (KRX: 000100) 2026 stock analysis: a stable base of prescription, OTC, consumer-health and API businesses meets a transformational catalyst — lazertinib (Lazcluze/Leclaza), out-licensed to Johnson & Johnson, generating milestone and royalty income in EGFR lung cancer. Bull case, single-asset risk, governance, and what global investors should watch.

Yuhan 000100 Korea Stocks

June 23, 2026

SK Bioscience Stock Outlook 2026: A Vaccine Maker's Pivot from COVID Windfall to CDMO Recurring Revenue

SK Bioscience (KRX: 302440) 2026 stock analysis: own vaccine pipeline (pneumococcal, shingles, flu), the pivot from one-off COVID manufacturing into recurring CDMO and cell-and-gene therapy contract production, German acquisition and glocalization strategy, plus the post-COVID earnings cliff and R&D-burn risks.

SK Bioscience 302440 vaccines

June 23, 2026

L&F Stock Outlook 2026: High-Nickel Cathode Leadership and the Metal-Price Pass-Through Problem

L&F (KOSDAQ 066970) 2026 stock analysis: high-nickel NCM/NCMA cathode leadership, cylindrical-cell and Tesla-linked supply chain exposure, North American IRA localization, metal-price pass-through margins, customer concentration, and Chinese LFP competition.

L&F 066970 cathode materials

June 23, 2026

Hanwha Solutions Stock Outlook 2026: Solar, Chemicals, and the Conglomerate Cycle Problem (009830)

Hanwha Solutions (009830) 2026 stock analysis: Hanwha Qcells US solar manufacturing and IRA 45X tax credits, PVC and caustic soda chemical cycle, advanced materials, conglomerate discount, and why this Korea-listed name blends clean-energy growth with petrochemical cyclicality.

Hanwha Solutions 009830 Hanwha Qcells

June 23, 2026

Hanwha Systems (272210) Stock Outlook 2026: Defense Electronics, ICT, and the Space-and-UAM Option

Hanwha Systems (272210) 2026 stock analysis: the defense-electronics core (radars, electro-optics, naval combat systems, C4I), ICT systems integration, and growth bets in LEO satellite communications (OneWeb) and UAM (Overair) — plus risks, valuation, and peer comparison versus Hanwha Aerospace.

272210 Hanwha Systems Korea Stocks

June 23, 2026

Hanwha Ocean Stock Outlook 2026: Korean Shipbuilding, Naval Defense, and the US Navy MRO Wildcard

Hanwha Ocean (042660) 2026 stock analysis: the former Daewoo Shipbuilding now repositioned by Hanwha toward high-value LNG carriers, submarine and surface-combatant defense exports, US Navy MRO via a US shipyard acquisition, and the cyclicality and turnaround risks investors must weigh.

Hanwha Ocean 042660 Korea Stocks

June 23, 2026

HLB Stock Outlook 2026 (KOSDAQ 028300): Rivoceranib, the FDA Binary, and Extreme Volatility

HLB (KOSDAQ 028300) 2026 stock analysis: rivoceranib liver-cancer combination therapy and the single US FDA approval catalyst, CRL/manufacturing/partner risk, the complex HLB Group affiliate structure, retail-driven volatility, and how a clinical-stage Korean biotech binary differs from Celltrion, Samsung Biologics, and Alteogen.

HLB 028300 KOSDAQ

June 23, 2026

HYBE Stock Outlook 2026 (352820): Multi-Label IP, the Weverse Platform, and K-Pop's Event-Driven Volatility

HYBE (352820) 2026 stock analysis: the BTS full-group return catalyst, multi-label IP diversification across BigHit, Source Music, Pledis and ADOR, Weverse fan-platform monetization, the US/Latin/Japan multi-home strategy, and the contract and governance risks that make this Korea-listed K-pop name uniquely event-driven.

HYBE 352820 K-pop

June 23, 2026

POSCO Holdings Stock Outlook 2026: Steel Cyclicality Meets a Lithium-to-Cathode Growth Story

POSCO Holdings (005490) 2026 stock analysis: the dual identity of a cyclical Korean steelmaker and a vertically integrated battery-materials platform spanning Argentine brine lithium, nickel, cathode via POSCO Future M, holding-company discount, dividends, and lithium-price risk.

POSCO Holdings 005490 POSCO

June 23, 2026

LG Energy Solution (373220) Stock Outlook 2026: EV Battery Leader Caught Between the EV Chasm and IRA Subsidies

LG Energy Solution (373220) 2026 stock analysis: global automaker order backlog, IRA AMPC production tax credits, GM joint-venture plants and ESS growth, the EV demand chasm, Chinese LFP competition (CATL/BYD), metal price pass-through, and capex intensity — for global investors in the US battery supply chain.

LG Energy Solution 373220 EV battery

June 23, 2026

SK Hynix (000660) Stock Outlook 2026: HBM Leadership and the Memory Cycle's Double Edge

SK Hynix (000660) 2026 stock analysis: the HBM franchise powering AI accelerators, #2 global DRAM position, NAND/Solidigm exposure, the boom-bust memory cycle, competition with Samsung and Micron, capex intensity, and how foreign investors access this Korea-listed memory leader.

SK Hynix 000660 HBM

May 20, 2026

Doosan Tesna (131970) Stock Outlook 2026: Semiconductor Wafer Testing in the AI Chip Era

Doosan Tesna (KOSPI 131970) 2026 outlook: wafer-level testing in the AI semiconductor value chain, Doosan Group ownership benefits and risks, fabless customer diversification opportunity, and what foreign investors need to know about this Korean back-end semiconductor services specialist.

131970 DoosanTesna KoreaStocks

May 20, 2026

Hanon Systems (018880) Stock Outlook 2026: EV Thermal Management and the Auto Parts Transition

Hanon Systems (KOSPI 018880) 2026 stock outlook: analyzing EV thermal management opportunity, battery thermal management systems, heat pump technology, competitive positioning against Denso and Valeo, and what foreign investors need to know about this Korean auto components supplier.

018880 HanonSystems KoreaStocks

May 20, 2026

SK Biopharmaceuticals (326030) Stock Outlook 2026: XCOPRI Revenue Ramp and the CNS Pipeline Bet

SK Biopharmaceuticals (KOSPI 326030) 2026 outlook: XCOPRI (cenobamate) US prescription growth, direct-sales model economics, CNS pipeline depth, competitive position in epilepsy treatment, and what foreign investors need to know before buying a Korean biotech.

326030 SKBiopharmaceuticals KoreaStocks

May 20, 2026

SK Square (402340) Stock Outlook 2026: NAV Discount, SK Hynix Stake, and the ICT Holding Play

SK Square (KOSPI 402340) 2026 outlook: analyzing the NAV discount structure, SK Hynix equity stake value, portfolio assets including 11Street, Tmap Mobility, and OneStore, and what foreign investors need to know about investing in a Korean ICT holding company.

402340 SKSquare KoreaStocks